Estrogen receptor variant ER‐α36 promotes tamoxifen agonist activity in glioblastoma cells

Glioblastoma (GBM) is a highly infiltrative and malignant primary brain tumor. Despite aggressive therapy, patients with GBM have a dismal prognosis with median survival of approximately 1 year. Tamoxifen (TAM), a selective estrogen receptor modulator (SERM), has been used to treat GBM for many year...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Qu, Chao, Ma, Jingyun, Zhang, Yejun, Han, Chao, Huang, Liang, Shen, Liming, Li, Hongyan, Wang, Xiaobo, Liu, Jing, Zou, Wei
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6317923/
https://ncbi.nlm.nih.gov/pubmed/30417588
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13868
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados